Clinical Trial Update: Zinc Effect on Inflammation and Cardiovascular Risk in HIV [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating zinc supplementation for its effects on inflammation and cardiovascular risk in HIV-associated inflammation, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection
• Zinc Deficiency

Drugs mentioned

• Zinc supplement (zinc)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Inflammation, Cardiovascular Diseases | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-06-12